https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08838-0
0
0
Effects of entecavir and tenofovir disoproxil fumarate on the incidence and severity of COVID-19 in patients with chronic hepatitis B - BMC Infectious Diseases - BMC Infectious Diseases
11/30/23 at 7:38am
Organization
Biomedcentral.com
Authors
Details
69 words
Summarize
Health COVID anti-hepatitis B virus HBV
Background Whether different anti-hepatitis B virus (HBV) drugs have different effects on COVID-19 is controversial. We aimed to evaluate the incidence of COVID-19 in chronic hepatitis B (CHB) patients receiving anti-HBV treatment, and to compare the impact o…
Create an account or login to join the discussion